Virablock 3G50®, the flagship innovation of Greencorp®, is an award-winning resistance inducer that treats viral diseases at the source. It activates the plant’s own Acquired Systemic Resistance (ASR), blocks viral movement, silences viral RNA and restores photosynthetic and vascular functions, helping crops recover and resume normal growth, yield and quality.
In commercial trials from the Andean highlands to Mediterranean greenhouse complexes, growers have recorded a reduction of up to 70 percent in symptom severity and harvests approaching standard targets, even under intense viral pressure. Because Virablock works through natural defense pathways, it leaves no chemical residues, integrates seamlessly into both organic and conventional programs, and supports compliance with the increasingly strict sustainability and residue regulations shaping global agriculture.
Founded in 2006 in northern Mexico, Greencorp® is one of the world’s most complete BioAg platforms, offering more than 80 biopesticides, biostimulants, biofertilizers and bioadjuvants, supported by a proprietary library of over 2,300 microbial strains and 1,900 botanical extracts. Every formulation is powered by advanced biotechnology, combining carefully selected botanical actives and microbial metabolites to deliver effective, natural solutions. Greencorp® will continue expanding the frontiers of biological crop care, but its mission remains constant: to deliver practical, scientific tools that help farmers produce more safely, sustainably and profitably.
Leave a Reply